基于ROS介导NLRP3炎症小体活化探讨凉血退紫方治疗过敏性紫癜大鼠作用机制研究
作者:
作者单位:

1.河南中医药大学第一附属医院儿科医院,郑州 450000;2.河南中医药大学儿科医学院,郑州 450046

作者简介:

通讯作者:

中图分类号:

R-33

基金项目:


Mechanism of Liangxue Tuizi Formula in the treatment of Henoch-Schönlein purpura rats via reactive oxygen species-mediated activation of NLRP3 inflammasome
Author:
Affiliation:

1. Pediatrics Hospital, the First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450000, China. 2. College of Pediatrics, Henan University of Chinese Medicine, Zhengzhou 450046

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 研究凉血退紫方(Liangxue Tuizi Formula, LXTZF)对过敏性紫癜大鼠活性氧(reactive oxygen species, ROS)介导的核苷酸结构寡聚化域(nucleotide-binding oligomerization domain, NOD)样受体热蛋白结构域相关蛋白3(nod-like receptor protein 3,NLRP3)炎症小体活化的影响,探讨其治疗过敏性紫癜的可能作用机制。 方法 将24只大鼠随机分为4组:空白组、模型组、LXTZF组、复方甘草酸苷(compound glycyrrhizin, CG)组,除空白组外,其余各组采用热性药物联合卵白蛋白(ovalbumin, OVA)建立过敏性紫癜大鼠模型。造模成功后,LXTZF组予LXTZF溶液7.47 g/kg灌胃,CG组予CG溶液13.5 mg/kg灌胃,空白组和模型组给予生理盐水灌胃,每天1次,连续4周。末次灌胃8 h后取材,苏木素-伊红(HE)染色法观察各组大鼠皮肤组织形态学变化;酶联免疫吸附法(enzyme-linked immunosorbent assay, ELISA)检测血清中白介素-18 (interleukin-18, IL-18)、白介素-1β(interleukin-1β, IL-1β)水平;免疫荧光检测大鼠皮肤组织中ROS水平变化;逆转录聚合酶链式反应(reverse transcription polymerase chain reaction, RT-PCR)法、免疫组化法及蛋白免疫印迹法(Western blot)检测大鼠皮肤组织中凋亡相关点样蛋白(apoptosis-associated speckle-like protein, ASC)、NLRP3、半胱氨酸蛋白酶-1(cysteinyl aspartate-specific protease-1, Caspase-1)基因信使核糖核酸(messenger RNA, mRNA)及蛋白表达。 结果 与空白组相比,模型组大鼠皮肤组织病理可见明显炎症细胞浸润;血清中IL-18、IL-1β含量均明显升高(P<0.05),皮肤组织中ROS水平显著升高(P<0.05),皮肤组织中ASC、NLRP3、Caspase-1 mRNA及蛋白表达水平显著升高(P<0.05)。与模型组相比,LXTZF组和CG组大鼠皮肤组织病理可见炎症细胞浸润减轻;血清中IL-18、IL-1β水平显著降低(P<0.05);皮肤组织中ROS水平显著降低(P<0.05),皮肤组织中ASC、NLRP3、Caspase-1 mRNA及蛋白表达水平显著降低(P<0.05)。 结论 凉血退紫方治疗过敏性紫癜发挥作用的机制可能与抑制ROS介导的NLRP3炎症小体活化相关。

    Abstract:

    Objective To study the effect of Liangxue Tuizi Formula (LXTZF) on reactive oxygen species (ROS)-mediated NOD-like receptor thermal protein domain associated protein 3 (NLRP3) inflammasome activation in Henoch-Sch?nlein purpura (HSP) rats, and to explore its possible mechanism in the treatment of HSP. Methods Twenty-four rats were divided randomly into four groups: control, model, LXTZF, and compound glycyrrhizin (CG) groups. Except for the control group, a model of HSP was established in the other groups by heat drugs combined with egg albumin. After successful modeling, rats in the LXTZF group were given LXTZF solution 7.47 g/kg, rats in the CG group were given CG solution 13.5 mg/kg by gavage, and rats in the control and model groups were given normal saline solution by gavage once a day for 4 weeks. Samples were collected 8 hours after the last gavage. Skin histopathology changes were observed by hematoxylin and eosin (HE) staining. Serum interleukin (IL)-18 and IL-1β levels were detected by enzyme-linked immunosorbent assay(ELISA). Changes in ROS levels in the skin were detected by immunofluorescence. Apoptosis-associated speckle-like protein (ASC), NLRP3, cysteinyl aspartate specific protease-1 (Caspase-1) mRNA and protein expression levels in rat skin were detected by real-time quantitative polymerase chain reaction (RT-PCR) and immunohistochemistry and Western blot, respectively. Results The skin pathology in the model group showed obvious inflammatory cell infiltration compared with the control group. Serum IL-18 and IL-1β levels were significantly increased (P<0.05), skin ROS levels were significantly increased (P<0.05), and skin ASC, NLRP3, Caspase-1 mRNA and protein expression levels were significantly increased (P<0.05). Inflammatory cell infiltration in the skin tissues of rats was alleviated in the LXTZF and CG groups compared with the model group, while serum levels of IL-18 and IL-1β were significantly decreased (P<0.05). ROS levels in the skin were significantly decreased (P<0.05), and mRNA and protein levels of ASC, NLRP3, and Caspase-1 in the skin were significantly decreased (P<0.05). Conclusions The mechanism of LXTZF in HSP may be related to the inhibition of ROS-mediated NLRP3 inflammasome activation.

    参考文献
    相似文献
    引证文献
引用本文

宋金婉,任献青,邢琼琼,李一凡,杨满翔.基于ROS介导NLRP3炎症小体活化探讨凉血退紫方治疗过敏性紫癜大鼠作用机制研究[J].中国比较医学杂志,2025,35(4):21~30.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2024-10-22
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-06-16
  • 出版日期: